Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.

Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Abstract Text:

Q Ma,D F Wyszynski,J J Farrell,A Kutlar,L A Farrer,C T Baldwin,M H Steinberg,Q Ma,D F Wyszynski,J J Farrell,A Kutlar,L A Farrer,C T Baldwin,M H Steinberg,Q Ma,D F Wyszynski,J J Farrell,A Kutlar,L A Farrer,C T Baldwin,M H Steinberg,

The increase in fetal hemoglobin (HbF) in response to hydroxyurea (HU) varies among patients with sickle cell anemia. Twenty-nine candidate genes within loci previously reported to be linked to HbF level (6q22.3-q23.2, 8q11-q12 and Xp22.2-p22.3), involved in metabolism of HU and related to erythroid progenitor proliferation were studied in 137 sickle cell anemia patients treated with HU. Three-hundred and twenty tagging single nucleotide polymorphisms (SNPs) for genotyping were selected based on HapMap data. Multiple linear regression and the nonlinear regression Random Forest method were used to investigate the association between SNPs and the change in HbF level after 2 years of treatment with HU. Both methods revealed that SNPs in genes within the 6q22.3-23.2 and 8q11-q12 linkage peaks, and also the ARG2, FLT1, HAO2 and NOS1 genes were associated with the HbF response to HU. Polymorphisms in genes regulating HbF expression, HU metabolism and erythroid progenitor proliferation might modulate the patient response to HU.The Pharmacogenomics Journal (2007) 7, 386-394; doi:10.1038/sj.tpj.6500433; published online 13 February 2007.

Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Publishing Authors By Initials

Q Ma,DF Wyszynski,JJ Farrell,A Kutlar,LA Farrer,CT Baldwin,MH Steinberg,Q Ma,DF Wyszynski,JJ Farrell,A Kutlar,LA Farrer,CT Baldwin,MH Steinberg,Q Ma,DF Wyszynski,JJ Farrell,A Kutlar,LA Farrer,CT Baldwin,MH Steinberg,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The pharmacogenomics journal

VOLUME: 7

Page Numbers: 386-94

Journal Abbreviation: Pharmacogenomics J.

ISSN: 1470-269X

DAY: 13

MONTH: 02

YEAR: 2007

Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101083949

Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.

AFFILIATION: 1Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pharmacogenomics J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea Related Publications

• A network model to predict the risk of death in sickle cell disease.
• Active suppressor tRNAs with a double helix between the D- and T-loops.
• Acute conversion of persistent atrial fibrillation during dofetilide initiation.
• Carotid and vertebral rete mirabile in man presenting with intraparenchymal hemorrhage: a case report.
• Commentary: defining and understanding adolescent romantic competence: progress, challenges, and implications.
• Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion.
• Cystectomy in the ninth decade: operative results and long-term survival outcomes.
• Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
• Differential gene expression profiling of Streptococcus mutans cultured under biofilm and planktonic conditions.
• Effectiveness of a dedicated day hospital for management of acute sickle cell pain.
• Epsilon PKC may contribute to the protective effect of hypothermia in a rat focal cerebral ischemia model.
• Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B.
• Expression of biofilm-associated genes of Streptococcus mutans in response to glucose and sucrose.
• Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.
• Gold toxicology in rheumatoid arthritis with particular emphasis on bone-marrow study.
• Induction of cyclin D1 by submicromolar concentrations of arsenite in human epidermal keratinocytes.
• Larval desperation and histamine: how simple responses can lead to complex changes in larval behaviour.
• Molecular organization of plasmid pER13 in Streptococcus thermophilus.
• Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes.
• Soybeans or soymilk: does it make a difference for cardiovascular protection? Does it even matter?
• Statistical education for medical students--concepts are what remain when the details are forgotten.
• Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia.
• The association between body mass index and clinical outcomes in acute lung injury.
• The diagnosis of congenital aneurysm of the pulmonary artery; report of two cases.
• Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke.
• Treatment of pneumonia with intramuscular aqueous penicillin once a day.
• Up-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas.
• Vesicle dynamics in time-dependent elongation flow: wrinkling instability.
• Viral caspase inhibitor p35, but not crmA, is neuroprotective in the ischemic penumbra following experimental stroke.
• [Comments on the origins of sexual identity.]